2021 SITC Press Releases

10/15/21 – SITC Announces Inaugural Class of Fellows to the Academy of Immuno-Oncology

8/10/21 – SITC Forward Fund Announces Recipients of 2021 Postdoctoral Cancer Immunotherapy Fellowships and Awards

8/5/21 – Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Urothelial Cancer

7/14/21 – Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immune Checkpoint Inhibitor-related Adverse Events

6/14/21 – SITC Steven A. Rosenberg, MD, PhD, Scholars Award: $150,000 in Funding for an Emerging Leader in Immuno-Oncology

5/27/21 – Diversity Panel Discusses Asian Experience in Cancer Research Hosted by Society for Immunotherapy of Cancer and Others

5/20/21 – Oncology News Burst from FDA: Nivolumab

4/23/21 – Oncology News Burst from FDA: Loncastuximab Tesirine-lpyl

4/22/21 – Oncology News Burst from FDA: Dostarlimab-gxly

4/19/21 – Oncology News Burst from FDA: Nivolumab

4/14/21 – Oncology News Burst from FDA: Sacituzumab Govitecan

4/13/21 – SITC to Host Fundamental Two-Day Workshop Focused on Cytokines in Cancer Immunotherapy

4/8/21 – SITC to Host Back-to-Back Workshops on Tumor Cell Surfaceome and Bispecific T cell Engagers

4/7/21 – Oncology News Burst from FDA: Sacituzumab Govitecan

4/1/21 – SITC Announces Two Spatial Technology Awards for Early Career Scientists to Advance Cancer Immunotherapy Research

4/1/21 – Oncology News Burst from FDA: Isatuximab-irfc

3/29/21 – Oncology News Burst from FDA: Idecabtagene Vicleucel

3/23/21 – Oncology News Burst from FDA: Pembrolizumab

3/5/21 – SITC to Host Virtual Leadership Institute Focusing on Professional Development for Women in Cancer Immunotherapy

2/10/21 – SITC Announces $450,000 in Cancer Immunotherapy Fellowships for Early Career Scientists

2/10/21 – Oncology News Burst from FDA: Cemiplimab-rwlc

2/5/21 – Oncology News Burst from FDA: Lisocabtagene Maraleucel

1/25/21 – SITC Announces Mary Dean, JD, CAE, as its Executive Director

1/22/21 – Oncology News Burst from FDA: Nivolumab plus Cabozantinib

1/7/21 – SITC Publishes Clinical Immunotherapy Treatment Guidelines for Lymphoma